In brief, our results revealed that high-power MWA combined with anti-PD-1 significantly elevated the CD8+ T cell to Treg ratio in tumor tissue and increased the level of TNF-α in peripheral blood, suggesting that combined therapy with certain sophisticated matches holds the promise to enhance the systemic antitumor immune responses which are required for distant tumor control. Here, CD8A is linked to neoplasm.